Foreword
The clinical consequences of secondary hyperparathyroidism: focus on clinical outcomes
Achieving therapeutic targets in the treatment of secondary hyperparathyroidism
The need for better control of secondary hyperparathyroidism
Modulation and action of the calcium-sensing receptor
Clinical experience with cinacalcet HCl
Causes and therapy of microinflammation in renal failure
Interleukin/cytokine profiles in haemodialysis and in continuous peritoneal dialysis
Effect of recombinant human erythropoietin on inflammatory status in dialysis patients
Anaemia after renal transplantation
Vascular calcification in patients with end-stage renal disease
Inflammatory proteins as predictors of cardiovascular disease in patients with end-stage renal disease
Could anti-inflammatory cytokine therapy improve poor treatment outcomes in dialysis patients?